Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus As-Needed, Short-Acting β₂ Agonist: Real-World Effectiveness in pAtients without Optimally Controlled asThma (REACT) Study

References

• BatemanED, HurdSS, BarnesPJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Resp J. 2008;31(1):143–178. doi:10.1183/09031936.00138707
   PubMed Web of Science ®Google Scholar
• Global strategy for asthma management and prevention; 2020 Available from: https://ginasthma.org/wp-content/uploads/2020/04/GINA-2020-full-report_-final-_wms.pdf. Accessed 515, 2020.
   Google Scholar
• PartridgeMR, van der MolenT, MyrsethSE, BusseWW. Attitudes and actions of asthma patients on regular maintenance therapy: the Inspire study. BMC Pulm Med. 2006;6(1):13. doi:10.1186/1471-2466-6-1316772035
   PubMedGoogle Scholar
• SuN, LinJ, ChenP, et al. Evaluation of asthma control and patient’s perception of asthma: findings and analysis of a nationwide questionnaire-based survey in China. J Asthma. 2013;50(8):861–870. doi:10.3109/02770903.2013.80834623713625
   PubMed Web of Science ®Google Scholar
• PriceD, FletcherM, van der MolenT. Asthma control and management in 8000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ Prim Care Respir Med. 2014;24(1):14009. doi:10.1038/npjpcrm.2014.924921985
   PubMed Web of Science ®Google Scholar
• KunaP, CreemersJP, VondraV, et al. Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma. Respir Med. 2006;100(12):2151–2159. doi:10.1016/j.rmed.2006.03.01616701989
   PubMed Web of Science ®Google Scholar
• LallooUG, MalolepszyJ, KozmaD, et al. Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma. Chest. 2003;123(5):1480–1487. doi:10.1378/chest.123.5.148012740264
   PubMed Web of Science ®Google Scholar
• StoloffSW, StempelDA, MeyerJ, StanfordRH, Carranza RosenzweigJR. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies. J Allergy Clin Immunol. 2004;113(2):245–251. doi:10.1016/j.jaci.2003.10.01114767437
   PubMed Web of Science ®Google Scholar
• KewKM, KarnerC, MindusSM, FerraraG. Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children. Cochrane Database Syst Rev. 2013;12:CD009019.
   Google Scholar
• BarnesNC. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control study. Am J Respir Crit Care Med. 2004;170(8):830–831. doi:10.1164/rccm.240800615475405
   PubMed Web of Science ®Google Scholar
• TunceliO, WilliamsSA, KernDM, et al. Comparative effectiveness of budesonide-formoterol combination and fluticasone-salmeterol combination for asthma management: a United States retrospective database analysis. J Allergy Clin Immunol Pract. 2014;2(6):719–726. doi:10.1016/j.jaip.2014.07.01625439363
   PubMed Web of Science ®Google Scholar
• ZhongN, LinJ, MehtaP, NgamjanyapornP, WuTC, YunusF. Real-life effectiveness of budesonide/formoterol maintenance and reliever therapy in asthma patients across Asia: SMARTASIA study. BMC Pulm Med. 2013;13:22.23557023
   PubMed Web of Science ®Google Scholar
• KardosP. Budesonide/formoterol maintenance and reliever therapy versus free-combination therapy for asthma: a real-life study. Pneumologie. 2013;67(8):463–470. doi:10.1055/s-0033-134434923904191
   PubMedGoogle Scholar
• JuniperEF, BousquetJ, AbetzL, BatemanED. Identifying ‘well-controlled’ and ‘not well-controlled’ asthma using the asthma control questionnaire. Respir Med. 2006;100(4):616–621. doi:10.1016/j.rmed.2005.08.01216226443
   PubMed Web of Science ®Google Scholar
• TepperRS, WiseRS, CovarR, et al. Asthma outcomes: pulmonary physiology. J Allergy Clin Immunol. 2012;129(3):S65–S87. doi:10.1016/j.jaci.2011.12.98622386510
   PubMed Web of Science ®Google Scholar
• JuniperEF, SvenssonK, MorkAC, StahlE. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med. 2005;99(5):553–558. doi:10.1016/j.rmed.2004.10.00815823451
   PubMed Web of Science ®Google Scholar
• KunaP, PetersMJ, ManjraAI, et al. Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. Int J Clin Pract. 2007;61(5):725–736. doi:10.1111/j.1742-1241.2007.01338.x17362472
   PubMed Web of Science ®Google Scholar
• VogelmeierC, D’UrzoA, PauwelsR, et al. Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option? Eur Respir J. 2005;26(5):819–828. doi:10.1183/09031936.05.0002830516264042
   PubMed Web of Science ®Google Scholar
• O’ByrnePM, BisgaardH, GodardPP, et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med. 2005;171(2):129–136. doi:10.1164/rccm.200407-884OC15502112
   PubMed Web of Science ®Google Scholar
• RabeKF, AtienzaT, MagyarP, LarssonP, JorupC, LallooUG. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet. 2006;368(9537):744–753. doi:10.1016/S0140-6736(06)69284-216935685
   PubMed Web of Science ®Google Scholar
• RabeKF, PizzichiniE, StallbergB, et al. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial. Chest. 2006;129(2):246–256. doi:10.1378/chest.129.2.24616478838
   PubMed Web of Science ®Google Scholar
• ScicchitanoR, AalbersR, UkenaD, et al. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Curr Med Res Opin. 2004;20(9):1403–1418. doi:10.1185/030079904X205115383189
   PubMed Web of Science ®Google Scholar
• QuirceS, BarcinaC, PlazaV, et al. A comparison of budesonide/formoterol maintenance and reliever therapy versus conventional best practice in asthma management in Spain. J Asthma. 2011;48(8):839–847. doi:10.3109/02770903.2011.61195421942354
   PubMed Web of Science ®Google Scholar
• Soes-PetersenU, KavaT, DahleR, LeiY, DamN. Budesonide/formoterol maintenance and reliever therapy versus conventional best standard treatment in asthma in an attempted ‘real life’ setting. Clin Respir J. 2011;5(3):173–182. doi:10.1111/j.1752-699X.2010.00217.x21679353
   PubMed Web of Science ®Google Scholar
• LouisR, JoosG, MichilsA, VandenhovenG. A comparison of budesonide/formoterol maintenance and reliever therapy vs. conventional best practice in asthma management. Int J Clin Pract. 2009;63(10):1479–1488. doi:10.1111/j.1742-1241.2009.02185.x19769705
   PubMed Web of Science ®Google Scholar
• O’ByrnePM, FitzGeraldJM, BatemanED, et al. Inhaled combined budesonide–formoterol as needed in mild asthma. N Engl J Med. 2018;378(20):1865–1876. doi:10.1056/NEJMoa171527429768149
   PubMed Web of Science ®Google Scholar
• SobierajDM, WeedaER, NguyenE, et al. Association of inhaled corticosteroids and long-acting β-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma: a systematic review and meta-analysis. J Am Med Assoc. 2018;319(14):1485–1496. doi:10.1001/jama.2018.2769
   PubMed Web of Science ®Google Scholar
• BeasleyR, BraithwaiteI, SempriniA, et al. ICS-formoterol reliever therapy stepwise treatment algorithm for adult asthma. Eur Resp J. 2020;55(1):1901407. doi:10.1183/13993003.01407-2019
   PubMed Web of Science ®Google Scholar
• JenkinsCR, BatemanED, SearsMR, O’ByrnePM. What have we learnt about asthma control from trials of budesonide/formoterol as maintenance and reliever? Respirology. 2020;10:1111.
   Google Scholar
• BeasleyR, HollidayM, ReddelHK, et al. Controlled trial of budesonide-formoterol as needed for mild asthma. N Engl J Med. 2019;380(21):2020–2030. doi:10.1056/NEJMoa190196331112386
   PubMed Web of Science ®Google Scholar
• HardyJ, BaggottC, FingletonJ, et al. Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial. Lancet. 2019;394(10202):919–928. doi:10.1016/S0140-6736(19)31948-831451207
   PubMed Web of Science ®Google Scholar